GSK-3β inhibition by curcumin mitigates amyloidogenesis via TFEB activation and anti-oxidative activity in human neuroblastoma cells-Reference-Cited by-同舟云学术

GSK-3β inhibition by curcumin mitigates amyloidogenesis via TFEB activation and anti-oxidative activity in human neuroblastoma cells

Published:2020-07-28 Issue:11-12 Volume:54 Page:918-930
ISSN:1071-5762
Container-title:Free Radical Research
language:en
Short-container-title:Free Radical Research

Author:

Song Hyun-Chul¹,Chen Yubing¹,Chen Yingqing²³,Park Jeongmin¹,Zheng Min⁴,Surh Young-Joon⁵,Kim Uh-Hyun²,Park Jeong Woo¹,Yu Rina⁶,Chung Hun Taeg¹,Joe Yeonsoo¹

Affiliation:

1. Department of Biological Sciences, University of Ulsan, Ulsan, Republic of Korea

2. National Creative Research Laboratory for Ca2+ signaling Network, Chonbuk National University Medical School, Jeonju, Republic of Korea

3. D, Dalian, China

4. Department of Neurology, Affliated Hospital of YanBian University, Yanji, China

5. Tumor microenvironment Global Core Research Center and Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Republic of Korea

6. Department of Food Science and Nutrition, University of Ulsan, Ulsan, South Korea

Funder

National Research Foundation of Korea

Ministry of Education

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

General Medicine,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10715762.2020.1791843

Reference63 articles.